Skip to main content

ÍS
EN

Forsíða

Forsíða

Hákon Hrafn Sigurðsson - Professor

Hákon Hrafn Sigurðsson

–

School of Health Sciences

Hákon Hrafn Sigurðsson

Professor

Location
Hagi / Ha-313
Phone
525 - 5821
Email
hhs [at] hi.is

Unit
Faculty of Pharmaceutical Sciences
Website
http://www.hi.is/~hhs
Published Work
Hákon Hrafn Sigurðsson - published work

Curriculum Vitae
Hákon Hrafn Sigurðsson - Curriculum Vitae
ORCID site
https://orcid.org/0000-0003-4074-9182
Research portal – Hákon Hrafn Sigurðsson

Published works

2021

Age-related ocular conditions: Current treatments and role of cyclodextrin-based nanotherapiesInternational Journal of Pharmaceutics

2020

In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye InflammationNanomaterials

2019

Nepafenac-Loaded Cyclodextrin/Polymer Nanoaggregates: A New Approach to Eye Drop FormulationMaterials
Cyclodextrin–Amphiphilic Copolymer Supramolecular Assemblies for the Ocular Delivery of NatamycinNanomaterials

2013

Mucus as a barrier to lipophilic drugsInternational Journal of Pharmaceutics

2012

Cross-linked hydroxypropyl-beta-cyclodextrin and gamma-cyclodextrin nanogels for drug delivery: Physicochemical and loading/release propertiesCarbohydrate Polymers

2011

Drug loading in cyclodextrin polymers: dexamethasone model drugJournal of Inclusion Phenomena and Macrocyclic Chemistry

2010

Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspensionEuropean Journal of Pharmaceutics and Biopharmaceutics
gamma-Cyclodextrin hydrogels and semi-interpenetrating networks for sustained delivery of dexamethasoneCarbohydrate Polymers

2008

Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerationsPharmazie

2007

Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eyeActa Ophthalmologica Scandinavica
Dexamethasone delivery to posterior segment of the eyeJournal of Inclusion Phenomena and Macrocyclic Chemistry

2006

Assessment of mucoadhesion by a resonant mirror biosensorInternational Journal of Pharmaceutics
Ocular powder: Dry topical formulations of timolol are well tolerated in rabbitsJournal of Ocular Pharmacology and Therapeutics

2005

Ocular powder: Irritation studies of dry formulations of topical timololInvestigative Ophthalmology & Visual Science
Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administrationJournal of Controlled Release

2004

Preparation of solid drug/cyclodextrin complexes of acidic and basic drugsPharmazie

2003

The effects of cyclodextrins on topical delivery of hydrocortisone: the aqueous diffusion layerStp Pharma Sciences

2002

Cyclodextrins and drug permeability through semi-permeable cellophane membranesInternational Journal of Pharmaceutics
Mucoadhesive sustained drug delivery system based on cationic polymer and anionic cyclodextrin/triclosan complexJournal of Inclusion Phenomena and Macrocyclic Chemistry
The effects of cyclodextrins on hydrocortisone permeability through semi-permeable membranesJournal of Inclusion Phenomena and Macrocyclic Chemistry

2001

Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal sprayInternational Journal of Pharmaceutics
Sustained drug delivery system based on a cationic polymer and an anionic drug/cyclodextrin complexPharmazie

1998

Cyclodextrins as co-enhancers in dermal and transdermal drug deliveryPharmazie

Keywords for Specialisation:

Pharmaceutics and Physical Pharmacy

Ocular drug delivery

Drug transport through membranes

Mucoadhesion (polymers